Global Synthetic Biology Platforms Market - Industry Trends and Forecast to 2028

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Synthetic Biology Platforms Market - Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Apr 2021
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Synthetic Biology Platforms Market, By Tool and Technology (Tool and Technology), Applications (Medical Applications, Industrial Applications, Food and Agriculture and Environmental Applications), Product (Core Product and Enabling Product), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Synthetic Biology Platforms Market Market Analysis and Insights  : Global Synthetic Biology Platforms Market

Data Bridge Market Research analyses that the synthetic biology platforms market will exhibit a CAGR of around 21.9% for the forecast period of 2021-2028. Rising demand for synthetic genes and cells will drive the growth of synthetic biology platforms market.

Synthetic biology is a branch of science that involves redesigning of organisms by engineering them to develop new abilities. Synthetic biology is a combination of biotechnology, electrical and computer engineering, molecular engineering, biophysics, evolutionary biology and genetic engineering. It is used to solve the problems in manufacturing, medicine and agriculture.

Rising research and development activities on synthetic biology will create lucrative growth opportunities for the synthetic biology platforms market. Increased expenditure by the government on the drug discovery and synthetic biological products will also foster the growth of synthetic biology platforms market. Rising demand and application of synthetic biology platforms by pharmaceutical companies is again propelling the market growth.

However, rising environmental and safety concerns will derail the market growth rate. Dearth of adequate technological infrastructure and lack of skilled personnel in low and middle class economies will challenge the market growth. Rising levelness of biological parts will restrain the market scope of growth.

This synthetic biology platforms market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research synthetic biology platforms market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Synthetic Biology Platforms Market Scope and Market Size

The synthetic biology platforms market is segmented on the basis of tool and technology, applications and product. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of tool and technology, the synthetic biology platforms market is segmented into tool and technology. Tool segment is further segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms and xeno-nucleic acids. Technology is further segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modelling, microfluidics, nanotechnology and computational modelling.
  • On the basis of applications, the synthetic biology platforms market is segmented into medical applications, industrial applications, food and agriculture and environmental applications. Medical applications segment is further segmented into pharmaceuticals, drug discovery and therapeutics and artificial tissue and tissue regeneration. Industrial applications segment is sub-segmented into, biofuel and renewable energy, biomaterials and green chemicals and industrial enzymes. Environmental applications are also further segmented into bioremediation and bio sensing.
  • On the basis of product, the synthetic biology platforms market is segmented into core product and enabling product. Core product is further segmented into synthetic DNA, synthetic genes, synthetic cells, XNA (Xeno nucleic acid) and chassis organisms. Enabling product is further segmented into DNA synthesis and oligonucleotide synthesis.

Synthetic Biology Platforms Market Country Level Analysis

The synthetic biology platforms market is analysed and market size insights and trends are provided by country, tool and technology, applications and product as referenced above.

The countries covered in the synthetic biology platforms market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the synthetic biology platforms market owing to the prevalence of advanced healthcare technology and rising awareness among the consumers. Upsurge in demand for synthetic biology platforms by pharmaceutical and biopharmaceutical companies will again propel the market growth in this region. Asia-Pacific region is expected to undergo the highest growth rate during the forecast period. This signifies that the region will score highest compound annual growth rate (CAGR) for the forecast period. This is because of the ever-rising geriatric population coupled with rising prevalence of chronic diseases. Rising public and private expenditure to improve the healthcare infrastructure will create lucrative growth opportunities for the synthetic biology platforms market in this region.

The country section of the synthetic biology platforms market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Synthetic biology platforms market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the synthetic biology platforms market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Synthetic Biology Platforms Market Share Analysis

The synthetic biology platforms market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to synthetic biology platforms market.

The major players covered in the synthetic biology platforms market report are Thermo Fisher Scientific Inc., Merck KGaA, Novozymes, Agilent Technologies, Inc., Precigen., GenScript, Twist Bioscience., Synthetic Genomics Inc., Codexis., Synthego, Eurofins Scientific, ATUM, TeselaGen., Integrated DNA Technologies, Inc., New England Biolabs., Igenbio, Inc., Bristol-Myers Squibb Company, Amyris, Ginkgo Bioworks and Integrated DNA Technologies, Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The synthetic biology platforms market will exhibit a CAGR of around 21.9% for the forecast period of 2021-2028.
The major players covered in the synthetic biology platforms market report are Thermo Fisher Scientific Inc., Merck KGaA, Novozymes, Agilent Technologies, Inc., Precigen., GenScript, Twist Bioscience., Synthetic Genomics Inc., Codexis., Synthego, Eurofins Scientific, ATUM, TeselaGen., Integrated DNA Technologies, Inc., New England Biolabs., Igenbio, Inc., Bristol-Myers Squibb Company, Amyris, Ginkgo Bioworks, and Integrated DNA Technologies, Inc.
Rising environmental and safety concerns will derail the market growth rate. The dearth of adequate technological infrastructure and lack of skilled personnel in low and middle-class economies will challenge market growth.
The synthetic biology platforms market is segmented on the basis of tools and technology, applications, and products.
Increased expenditure by the government on drug discovery and synthetic biological products will also foster the growth of the synthetic biology platforms market. Rising demand and application of synthetic biology platforms by pharmaceutical companies is again propelling the market growth.